Innovative Hybrid Compounds Targeting Tuberculosis: Development, Characterization and Bioefficacy analysis of 6-substituted-2-Chloroquinoline-3-Carbaldehyde Hydrazide Ester derivatives

Authors

  • Vaibhav V. Potdar Goa College of Pharmacy, Panaji, Goa University, Goa, India
  • Arun B. Joshi Goa College of Pharmacy, Panaji, Goa University, Goa, India

DOI:

https://doi.org/10.25004/IJPSDR.2024.160309

Keywords:

2-Chloroquinoline-3-carbaldehyde, Hydrazide, Anit-TB, Hybrid molecules, Mycobacterium tuberculosis, ADME

Abstract

This study delves into the biological activity of ester compounds obtained from analogues of 6-substituted-2-chloroquinoline-3-carbaldehyde hydrazide, aiming to exploit the combined antitubercular properties of quinoline and hydrazide to create innovative hybrid compounds. The molecules underwent a meticulous multi-step synthesis process, followed by purification through recrystallization. Methodologies such as 1H NMR, 13C NMR, FTIR and Mass Spectrometry was used to confirm the molecular structures of developed derivatives. SWISSADME, an online tool, was utilized to predict the ADME properties, shedding light on their pharmacokinetic profiles. Evaluation of in vitro antitubercular activity employing the Alamar blue method highlighted compounds 4a and 4f, exhibiting noteworthy efficacy achieving threshold concentrations of 6.25 µg/ml for M. tuberculosis inhibition. These findings suggest the possibility of novel quinoline Scaffold as potential molecule for TB treatment, contributing to ongoing endeavors in TB drug discovery and potentially laying the groundwork to develop effective antitubercular therapies.

Downloads

Download data is not yet available.

References

Nair A, Greeny A, Nandan A. et al. Advanced drug delivery and therapeutic strategies for tuberculosis treatment. J. Nanobiotechnol.2023; 21: 414.Available from: doi.org/10.1186/s12951-023-02156-y

Singh H, Jindal S, Sing M, Sharma G, Kaur IP. Nano-Formulation of Rifampicin with Enhanced Bioavailability: Development, Characterization, and in-Vivo Safety. Int. J. Pharm. 2015; 485(1-2):138–151.Available from: doi.10.1016/j.ijpharm.2015.02.050.

Qi CC, Xu LR, Zhao CJ, Zhang HY, Li QY, Liu MJ, Zhang YX, Tang Z, Ma XX. Prevalence and Risk Factors of Tuberculosis among People Living with HIV/AIDS in China: A Systematic Review and Meta-Analysis. BMC Infect. Dis. 2023; 23: 584. Available from: doi.10.1186/s12879-023-08575-4

Dheda K, Barry III CE, Maartens G. Tuberculosis. The Lancet.2016; 387(10024) :1211-1226. Available from:doi. 10.1016/S0140-6736(15)00151-5

Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, at al for WHO's Global TB Programme. WHO's new end TB strategy. Lancet. 2015;385(9979):1799-1801. Available from: doi.10.1016/S0140-6736(15)60570-0

Ajani OO, Iyaye KT, Ademosun OT. Recent advances in chemistry and therapeutic potential of functionalized quinoline motifs – A Review. RSC Advances. 2022;12(29):18594–614.Available from: doi.10.1039/d2ra02896d

Elebiju OF, Ajani OO, Oduselu GO, Ogunnupebi TA, Adebiyi E. Recent advances in functionalized quinoline scaffolds and hybrids—exceptional pharmacophore in therapeutic medicine. Frontiers in Chemistry. 2023; 6:10. Available from: doi.10.3389/fchem.2022.1074331

Mandhane PG, Joshi RS, Mahajan PS, Nikam MD, Nagargoje DR, Gill CH. Synthesis, characterization and antimicrobial screening of substituted Quiazolinones derivatives. Arabian Journal of Chemistry. 2015 ;8(4):474–9. Available from : doi.10.1016/j.arabjc.2011.01.025

Korcz M, Sączewski F, Bednarski P, Kornicka A. Synthesis, structure, chemical stability, and in vitro cytotoxic properties of novel quinoline-3-carbaldehyde hydrazones bearing a 1,2,4-triazole or benzotriazole moiety. Molecules. 2018;23(6):1497. Available from: doi.10.3390/molecules23061497

Kumar R, Pathak D. Synthesis and biological evaluation of some novel quinoline derivatives bearing pyrazole moiety. Int J Pharm Sci Drug Res. 2023; 15(2):139-143.

Patel AJ, Dholakia AB, Patel VC. A green perspective: Synthesis of 2-chloro-3-formylquinolines and its derivatives. Synthetic Communications. 2020; 51(2):163–90. Available from: doi.10.1080/00397911.2020.1824277

Zeleke D, Eswaramoorthy R, Belay Z, Melaku Y. Synthesis and antibacterial, antioxidant, and molecular docking analysis of some novel quinoline derivatives. Journal of Chemistry. 2020:1–16. Available from: doi.10.1155/2020/1324096

Abdel-Wahab BF, Khidre RE, Farahat AA, El-Ahl A-AS. 2-chloroquinoline-3-carbaldehydes: Synthesis, reactions and applications. Arkivoc. 2012 ;2012(1):211–76. Available from: doi.10.3998/ark.5550190.0013.107

El-Samahy FA, Ibrahim NM, Mahran MR. The behavior of 2-chloroquinoline-3-carbaldehyde and 2-oxoquinoline-3-carbaldehyde toward stabilized methylene triphenyl phosphoranes and secondary amines. Phosphorus, Sulfur, and Silicon Related Elements. 2016; 191(1):59–64. Available from: doi.10.1080/10426507.2015.1085042

Mhaske GS, Sen A, Shah A, Sen D, Phadtare GR, Awate SS, Sakpal PH, Khiste RH, Neharkar VS. Synthesis, cytotoxicity, PDGFR inhibitory activity and docking study of novel 2-aminoquinoline-3-carboxamide derivatives as potential anticancer agents. Eur Chem Bull. 2023;12(Special Issue 1):292-305.

Subashini R, Roopan SM, Khan FN. Synthesis and free radical scavenging property of some quinoline derivatives. Journal of the Chilean Chemical Society. 2010;55(3):317–9. Available from: doi.10.4067/s0717-97072010000300008

Bahadur V, Mastronicola D, Singh AK, Tiwari HK, Pucillo LP, Sarti P, et al. Antigiardial activity of novel triazolyl-quinolone-based chalcone derivatives: When oxygen makes the difference. Frontiers in Microbiology. 2015;6. Available from: doi.10.3389/fmicb.2015.00256

Hamama WS, Ibrahim ME, Gooda AA, Zoorob HH. Recent advances in the chemistry of 2-chloroquinoline-3-carbaldehyde and related analogs. RSC Advances. 2018;8(16):8484–515.Available from: doi.10.1039/c7ra11537g

Zadsirjan V, Mahdizadeh SJ, Heravi MM, Heydari M. Synthesis of novel n-functionalized 4-aryl-tetrahydrobiquinoline-2,5-(1h,3h)-diones via one-pot three-component reaction: A joint experimental and computational study. Canadian Journal of Chemistry. 2018;96(12):1071–8.Available from :doi.10.1139/cjc-2017-0564

Gbe GD, Sagne JA, Doumade Z, Ané A. Synthesis of N-alkyl-3- (1H-benzimidazolyl) -2-chloroquinoline derivatives potential candidates against infectious organisms. African Journal of Pure and Applied Chemistry. 2021;15(2):8–12. Available from: doi.10.5897/ajpac2020.0857

Yasaei Z, Mohammadpour Z, Shiri M, Tanbakouchian Z, Fazelzadeh S. Isocyanide reactions toward the synthesis of 3-(oxazol-5-yl)quinoline-2-carboxamides and 5-(2-tosylquinolin-3-yl)oxazole. Frontiers in Chemistry. 2019;7: 433. Availablefrom: doi.10.3389/fchem.2019.00433

Sangwan K, Singh B. Antiproliferative activity of novel imatinib analogue as potential anticancer agents, synthesis and in vitro screening. Indian Journal of Pharmaceutical Education and Research. 2023;57(2s): s453-s458.Available from: doi.10.5530/ijper.57.2s.53

Insuasty D, Abonia R, Insuasty B, Quiroga J, Laali KK, Nogueras M, et al. Microwave-assisted synthesis of diversely substituted quinoline-based dihydropyridopyrimidine and dihydropyrazolopyridine hybrids. ACS Combinatorial Science. 2017; 19(8):555–63. Available from: doi.10.1021/acscombsci.7b00091

Saral A, Sudha P, Muthu S, Sevvanthi S, Sangeetha P, Selvakumari S. Vibrational spectroscopy, Quantum Computational and Molecular Docking Studies on 2-chloroquinoline-3-carboxaldehyde. Heliyon. 2021;7(7): e07529.Available from: doi.10.1016/j.heliyon. 2021.e07529

Govender H, Mocktar C, Koorbanally NA. Synthesis and bioactivity of quinoline‐3‐carboxamide derivatives. Journal of Heterocyclic Chemistry. 2018;55(4):1002–9. Available from: doi.10.1002/jhet.3132

Maigali SS, Abd-El-Maksoud MA, El-Hussieny M, Soliman FM, Abdel-Aziz MS, Shalaby E-SM. Chemistry of phosphorus ylides: Part 41 synthesis of antimicrobial agents from the reaction of amino antipyrine, coumarin- and quinoline-carbaldehyde with phosphacumulene and phosphaallene ylides. Journal of Chemical Research. 2014; 38(12):754–61. Available from: doi.10.3184/174751914x14179446629855

Guje PB, Chidrawar AB, Patwari SB, Madje BR, Rajani DP, Sangshetti JN, Damale M, PokalwarRU.Synthesis, molecular docking, antibacterial and antifungal activity study of novel-3-((1H-benzo[d]imidazole-2-ylthio)methyl)-2-chloroquinoline derivatives. Chem Biol Interface. 2020; 10(6):149-157.

Volovnenko TA, Tarasov AV, Zubatyuk RI, Shishkin OV, Turov AV, VolovenkoYuM. Interaction of 2-chloroquinoline- 3-carbaldehydes with 2-hetaryl- acetonitriles. Chemistry of Heterocyclic Compounds. 2009;45(12):1489–502.Available from: doi.10.1007/s10593-010-0456-7

Fekadu M, Zeleke D, Abdi B, Guttula A, Eswaramoorthy R, Melaku Y. Synthesis, in silico molecular docking analysis, pharmacokinetic properties and evaluation of antibacterial and antioxidant activities of fluoroquinolines. BMC Chemistry. 2022;16(1). Available from: doi.10.1186/s13065-022-00795-0

Suryanarayana K, Gangu KK, Kerru N, Khatana K, Satyanarayana B, Maddila S. Synthesis of a novel chloroquinoline, rhodanine encompassed 1,2,3-triazole scaffolds and molecular docking evaluation of their cytotoxicity. Journal of the Iranian Chemical Society. 2023;20(10):2643–55. Available from: doi.10.1007/s13738-023-02862-2

Noori M, Davoodi A, Iraji A, Dastyafteh N, Khalili M, Asadi M, et al. Design, synthesis, and in silico studies of quinoline-based-benzo[d]imidazole bearing different acetamide derivatives as potent α-glucosidase inhibitors. Scientific Reports. 2022 ;12(1): 14019. Available from: doi.10.1038/s41598-022-18455-7

Forozan R, Ghomi MK, Iraji A, Montazer MN, Noori M, Dastyafteh N, et al. Synthesis, in vitro inhibitor screening, structure–activity relationship, and Molecular Dynamic Simulation Studies of novel thioquinoline derivatives as potent α-glucosidase inhibitors. Scientific Reports. 2023;13(1). Available from :doi.10.1038/s41598-023-35140-5

Moghaddam FM, Moafi A, Ziadkhani A, Daneshfar M, Razaghdoost N. A facile and efficient route for the synthesis of thiopyran quinolines‐fused indole moiety using 2‐chloroquinoline‐3‐carbaldehydes. Chemistry Select. 2019;4(40):11683–6. Available from :doi.10.1002/slct.201902476

Bhardwaj N, Choudhary D, Pathania A, Baranwal S, Kumar P. Synthesis and molecular docking studies of quinoline derivatives as HIV non-nucleoside reverse transcriptase inhibitors. Turkish Journal of Chemistry. 2020;44(6):1623–41. Available from :doi.10.3906/kim-2004-14

Mandewale MC, Patil UC, Shedge SV, Dappadwad UR, Yamgar RS. A review on quinoline hydrazone derivatives as a new class of potent antitubercular and Anticancer Agents. Beni-Suef University Journal of Basic and Applied Sciences. 2017;6(4):354–61. Available from :doi.10.1016/j.bjbas.2017.07.005

Popiołek Ł. Hydrazide–Hydrazones as potential antimicrobial agents: Overview of the literature since 2010. Medicinal Chemistry Research. 2016;26(2):287–301. Available from :doi.10.1007/s00044-016-1756-y

Mahantheshappa SS, Shivanna H, Satyanarayan ND. Synthesis, antimicrobial, antioxidant, and ADMET studies of quinoline derivatives. European Journal of Chemistry. 2021; 12(1):37–44. Available from :doi.10.5155/eurjchem.12.1.37-44.2038

Golea L, Chebaki R, Laabassi M, Mosset P. Synthesis, characterization of some substituted Quinolines derivatives: DFT, computational, in silico ADME, molecular docking and biological activities. Chemical Data Collections. 2023; 43:100977. Available from :doi.10.1016/j.cdc.2022.100977

Kumar S, Bawa S, Drabu S, Panda BP. Design and synthesis of 2-chloroquinoline derivatives as non-azoles antimycotic agents. Medicinal Chemistry Research. 2010;20(8):1340–8. Available from :doi.10.1007/s00044-010-9463-6

Koopaei MN, Assarzadeh MJ, Almasirad A, Ghasemi-Niri SF, Amini M, Kebriaeezadeh A, et al. Synthesis and Analgesic Activity of Novel Hydrazide and Hydrazine Derivatives.Iran J Pharm Res. 2013;12(4):721–7.

Tamaddon F, Amrollahi MA, Sharafat L. A green protocol for chemoselective O-acylation in the presence of zinc oxide as a heterogeneous, reusable and eco-friendly catalyst. Tetrahedron Letters. 2005; 46(45):7841–4. Available from: doi.10.1016/j.tetlet.2005.09.005

Lourenço MC, Souza MV, Pinheiro AC, Ferreira M de, Gonçalves RS, Nogueira TC, et al. Evaluation of anti-tubercular activity of Nicotinic and isoniazid analogues. Arkivoc. 2007 ;( 15):181–91. Available from:doi.10.3998/ark.5550190.0008.f18

Degfie T, Endale M, Tafese T, Dekebo A, Shenkute K. In vitro antibacterial, antioxidant activities, molecular docking, and ADMET analysis of phytochemicals from roots of Hydnora Johannis. Applied Biological Chemistry. 2022; 65(1).Available from: doi.10.1186/s13765-022-00740-8.sm. 2022; 65(1):76

Downloads

Published

30-05-2024

Issue

Section

Research Article

How to Cite

“Innovative Hybrid Compounds Targeting Tuberculosis: Development, Characterization and Bioefficacy Analysis of 6-Substituted-2-Chloroquinoline-3-Carbaldehyde Hydrazide Ester Derivatives”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 16, no. 3, May 2024, pp. 378-86, https://doi.org/10.25004/IJPSDR.2024.160309.